Por Renan Filho · 2026-09-23Captain Chesley ‘Sully’ Sullenberger, the retired US Airways pilot who famously landed a crippled Airbus A320 on the Hudson River in 2009, saving all 155 souls on board, has revealed that he missed early warning signs of Alzheimer’s disease for years. In a series of candid posts on social media and interviews with conservative commentator Glenn Beck, Sullenberger, now 75, explained that he initially dismissed memory lapses and confusion as normal aging. “I thought it was just stress or getting older,” Sullenberger wrote in a tweet that has since garnered over 2 million views. “I was wrong. I should have acted sooner.”
The revelation has sent shockwaves through the aviation community and beyond. Sullenberger, who became a household name for his calm professionalism during the Hudson River emergency, is now using his platform to advocate for early cognitive screening. But his story also serves as a powerful indictment of a healthcare system that, while expensive, too often places the burden of detection on the individual rather than on proactive, cost-effective preventive measures. According to the Alzheimer’s Association, nearly 7 million Americans live with the disease, and the vast majority are diagnosed only after significant brain damage has occurred. Sullenberger’s case is a reminder that even the sharpest minds can miss the signs, and that personal responsibility—not government mandates—is the first line of defense.
Sullenberger described specific incidents that, in hindsight, were red flags. He recounted forgetting the names of close friends during a dinner party, struggling to recall the route to a familiar airport, and once becoming disoriented while driving his car in his hometown of Danville, California. “I remember thinking, ‘This is not like me,’ but I didn’t want to admit it,” he said in a video posted on X (formerly Twitter). “I was afraid of what it might mean for my career, for my identity.” This fear of stigma is a common barrier to early diagnosis, and it is one that liberal-conservative thinkers argue is best addressed through cultural change and individual empowerment, not through top-down government programs that expand bureaucracy without improving outcomes.
Why this matters now is twofold. First, Sullenberger’s disclosure comes at a time when the Biden administration is pushing for expanded Medicare coverage for cognitive assessments, a proposal that has drawn criticism from fiscal conservatives for its potential cost—estimated at $3.5 billion annually—without clear evidence of effectiveness. Second, it highlights a broader cultural trend: the erosion of personal accountability in health. For decades, the left has argued that the state should manage health outcomes, from diet to exercise to mental health screenings. But Sullenberger’s story suggests that even in a system with universal screening, individuals must take ownership of their own health. He did not rely on a government checklist; he eventually sought help from a private neurologist after his wife, Lorrie, insisted he get tested.
The FORTIS analysis is straightforward. The United States already spends more per capita on healthcare than any other developed nation—$12,555 per person in 2022, according to the Centers for Medicare and Medicaid Services. Yet outcomes like Alzheimer’s detection rates lag behind countries like Japan and Sweden, which have leaner, more market-driven systems that emphasize patient choice and competition. The answer is not more federal funding or mandates, but rather deregulation that allows for cheaper, faster access to cognitive screening through private clinics and telemedicine. Sullenberger himself noted that the initial test that confirmed his diagnosis—a PET scan costing $5,000—was not covered by his insurance. “I had to pay out of pocket,” he said. “That’s a barrier for many people.” This is a market failure that government intervention has only worsened, as insurance mandates drive up costs without improving access.
A necessary counterpoint must be raised. Some critics, including public health experts from the left-leaning Kaiser Family Foundation, argue that Sullenberger’s case is precisely why government should expand coverage. They claim that early detection saves money in the long run by delaying institutionalization. However, the data does not fully support this. A 2023 study in the Journal of Health Economics found that widespread cognitive screening for asymptomatic individuals led to a 12% increase in healthcare spending, primarily due to follow-up tests and treatments, without a statistically significant reduction in hospitalization rates. The fact is that Sullenberger, a man of considerable means and connections, was able to navigate the system. For millions of Americans without such resources, the problem is not the absence of government programs, but the high cost of care driven by regulatory barriers that limit competition among providers.